STK32A and gastric adenocarcinoma: In STAD, the overexpression of STK32A gene (p = 0.001) and the hypomethylation of the corresponding CpG probes cg09088988 (p = 0.013) was found to be significant in lower overall survival, suggesting its use as a prognostic and diagnostic marker in STAD patients.